Oncology (genomic predictors of cancer treatment response)
Anil Potti: Duke genomic predictor research, 2010 to 2015
Duke University School of Medicine
Misconduct found Resigned from Duke in 2010. In a 2015 voluntary settlement with ORI he agreed that any US Public Health Service funded research he took on within five years would be supervised, and to stay off PHS advisory roles for five years, without admitting or denying ORI's findings.1,2
Papers
| Paper | Action | Date | Reason stated |
|---|---|---|---|
| Nine published papers reporting genomic predictors or their validation Multiple journals, 2006 to 2009 https://www.federalregister.gov/documents/2015/11/09/2015-28437/findings-of-research-misconduct1,2 | Retracted | 2010 onward | ORI said nine papers were retracted after Duke's investigation, and found false research data in them. |
Investigations
- US Office of Research Integrity (ORI), following a Duke University investigation, 9 November 2015ORI found he engaged in research misconduct by including false research data in a grant application, a submitted manuscript, a research record and nine published papers. He neither admits nor denies the findings.1
Response
Under the voluntary settlement he neither admits nor denies ORI's findings. Retraction Watch reported he said he had no intention of applying for NIH funding again.1,2
Sources
- Federal Register, US Department of Health and Human Services, Office of Research Integrity, Findings of Research Misconduct (Anil Potti) (9 November 2015)
- Retraction Watch, It's official: Anil Potti faked cancer research data, say Feds (7 November 2015)